{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:01:24Z","timestamp":1788602484487,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["RES0037745"],"award-info":[{"award-number":["RES0037745"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.advnut.2025.100464","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:34:19Z","timestamp":1749868459000},"page":"100464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perspective: Implications of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on the Immune System during Cancer Chemotherapy: Perspectives from Current Clinical Evidence"],"prefix":"10.1016","volume":"16","author":[{"given":"Jaqueline","family":"Munhoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Mazurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-4767","authenticated-orcid":false,"given":"Catherine J","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.advnut.2025.100464_bib2","series-title":"Cancer Facts & Figures 2024","author":"Society","year":"2024"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mpmed.2022.10.005","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"51","author":"Aboud","year":"2023","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.emc.2013.09.002","article-title":"An approach to chemotherapy-associated toxicity","volume":"32","author":"Livshits","year":"2014","journal-title":"Emerg. Med. Clin. North Am."},{"issue":"11","key":"10.1016\/j.advnut.2025.100464_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.advnut.2025.100464_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.10969","article-title":"Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(\u2217)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro","volume":"104","author":"Correale","year":"2003","journal-title":"Int. J. Cancer."},{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ijc.28070","article-title":"Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death","volume":"133","author":"Hodge","year":"2013","journal-title":"Int. J. Cancer."},{"issue":"19","key":"10.1016\/j.advnut.2025.100464_bib8","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/bloodadvances.2020001797","article-title":"Lingering effects of chemotherapy on mature T cells impair proliferation","volume":"4","author":"Das","year":"2020","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.advnut.2025.100464_bib9","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.advnut.2025.100464_bib10","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1158\/0008-5472.CAN-14-0067","article-title":"Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner","volume":"74","author":"Volk-Draper","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.advnut.2025.100464_bib11","article-title":"Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-alpha and VEGF pathway in progressive of cardiovascular damage","volume":"76","author":"Syukri","year":"2022","journal-title":"Ann. Med. Surg. (Lond)."},{"issue":"9","key":"10.1016\/j.advnut.2025.100464_bib12","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.fct.2011.05.012","article-title":"Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFkappaB, TNF-alpha and caspase-3 expression in wistar rats","volume":"49","author":"Arjumand","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.advnut.2025.100464_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154791","article-title":"Modulation of 5-fluorouracil activation of toll-like\/MyD88\/NF-kappaB\/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic","volume":"125","author":"Justino","year":"2020","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.advnut.2025.100464_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-017-9870-x","article-title":"Chemotherapy-induced metastasis: mechanisms and translational opportunities","volume":"35","author":"Karagiannis","year":"2018","journal-title":"Clin. Exp. Metastasis."},{"issue":"8","key":"10.1016\/j.advnut.2025.100464_bib15","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1002\/fsn3.3409","article-title":"The effectiveness of omega-3 fatty acids on health outcomes in women with breast cancer: a systematic review","volume":"11","author":"Osouli-Tabrizi","year":"2023","journal-title":"Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-019-05331-8","article-title":"Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts","volume":"177","author":"Newell","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jn\/nxy224","article-title":"Treatment with DHA modifies the response of MDA-MB-231 breast cancer cells and tumors from nu\/nu Mice to Doxorubicin through apoptosis and cell cycle arrest","volume":"149","author":"Newell","year":"2019","journal-title":"J. Nutr."},{"key":"10.1016\/j.advnut.2025.100464_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109018","article-title":"Docosahexaenoic acid enrichment of tumor phospholipid membranes increases tumor necroptosis in mice bearing triple negative breast cancer patient-derived xenografts","volume":"107","author":"Newell","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.advnut.2025.100464_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnesp.2024.04.002","article-title":"The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: a systematic review and meta-analysis","volume":"61","author":"Wibowo","year":"2024","journal-title":"Clin. Nutr. ESPEN."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111601","article-title":"Roles and therapeutic opportunities of omega-3 long-chain polyunsaturated fatty acids in lung cancer","volume":"28","author":"Luo","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12885-017-3248-y","article-title":"Effects of omega-3 fatty acids on patients undergoing surgery for gastrointestinal malignancy: a systematic review and meta-analysis","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.advnut.2025.100464_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1072653","article-title":"The influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: a scoping review","volume":"10","author":"Dempsey","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.advnut.2025.100464_bib23","series-title":"Possible mechanisms of \u03c9-3 PUFA anti-tumour action, Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer","first-page":"3","author":"Sawyer","year":"2010"},{"issue":"8","key":"10.1016\/j.advnut.2025.100464_bib24","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijms18081784","article-title":"A critical review on the effect of docosahexaenoic acid (DHA) on cancer cell cycle progression","volume":"18","author":"Newell","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.advnut.2025.100464_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s11745-012-3717-7","article-title":"Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells","volume":"47","author":"Ewaschuk","year":"2012","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jcm5020015","article-title":"Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy","volume":"5","author":"D'Eliseo","year":"2016","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.advnut.2025.100464_bib27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/cancers13061206","article-title":"N-3 long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic acid, and the role of supplementation during cancer treatment: a scoping review of current clinical evidence","volume":"13","author":"Newell","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.advnut.2025.100464_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2022.102458","article-title":"Development of a novel database to review and assess the clinical effects of EPA and DHA omega-3 fatty acids, Prostaglandins Leukot. Essent","volume":"183","author":"Bernasconi","year":"2022","journal-title":"Fatty Acids"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/01635581.2014.847964","article-title":"High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study","volume":"66","author":"Hutchins-Wiese","year":"2014","journal-title":"Nutr. Cancer."},{"issue":"4","key":"10.1016\/j.advnut.2025.100464_bib30","first-page":"769","article-title":"Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial, Nutr","volume":"36","author":"de la Rosa Oliva","year":"2019","journal-title":"Hosp"},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0007114511005551","article-title":"Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study","volume":"108","author":"Finocchiaro","year":"2012","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.advnut.2025.100464_bib32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/01635581.2019.1659380","article-title":"Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory factors and tumor marker CEA in colorectal cancer patients undergoing chemotherapy: a randomized, double-blind, placebo-controlled clinical trial","volume":"72","author":"Haidari","year":"2020","journal-title":"Nutr. Cancer."},{"issue":"9","key":"10.1016\/j.advnut.2025.100464_bib33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11745-013-3816-0","article-title":"Fish oil decreases C-reactive protein\/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients","volume":"48","author":"Mocellin","year":"2013","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.advnut.2025.100464_bib34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jhn.12471","article-title":"Oral fish oil positively influences nutritional-inflammatory risk in patients with haematological malignancies during chemotherapy with an impact on long-term survival: a randomised clinical trial","volume":"30","author":"Chagas","year":"2017","journal-title":"J. Human Nutr. Diet."},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/01635581.2012.643133","article-title":"Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients","volume":"64","author":"Silva","year":"2012","journal-title":"Nutr. Cancer."},{"key":"10.1016\/j.advnut.2025.100464_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11745-011-3643-0","article-title":"Fish oil supplementation improves neutrophil function during cancer chemotherapy","volume":"47","author":"Bonatto","year":"2010","journal-title":"Lipids"},{"issue":"37","key":"10.1016\/j.advnut.2025.100464_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011971","article-title":"Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer","volume":"97","author":"Lu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.advnut.2025.100464_bib38","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/sj.bjc.6605441","article-title":"Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial","volume":"101","author":"Bougnoux","year":"2009","journal-title":"Br. J. Cancer."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib39","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1038\/s41598-023-28411-8","article-title":"Anti-inflammatory effect of combining fish oil and evening primrose oil supplementation on breast cancer patients undergoing chemotherapy: a randomized placebo-controlled trial","volume":"13","author":"Arsic","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4559-z","article-title":"Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain","volume":"167","author":"Lustberg","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.advnut.2025.100464_bib41","series-title":"Study Quality Assessment Tools","year":"2021"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1139\/cjpp-2020-0317","article-title":"Metabolically healthy obesity: is there a link with polyunsaturated fatty acid intake and status?","volume":"99","author":"Arsic","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.advnut.2025.100464_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib44","first-page":"263","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention, Signal Transduct","volume":"6","author":"Zhao","year":"2021","journal-title":"Target Ther."},{"issue":"16","key":"10.1016\/j.advnut.2025.100464_bib45","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1074\/jbc.271.16.9503","article-title":"STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.advnut.2025.100464_bib46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2567.2003.01608.x","article-title":"Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C\/EBPbeta and signal transducer and activator of transcription-3","volume":"108","author":"Agrawal","year":"2003","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.advnut.2025.100464_bib47","first-page":"5139","article-title":"Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer","volume":"17","author":"Shimura","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.advnut.2025.100464_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9701574","article-title":"Preoperative serum interleukin-6 is a potential prognostic factor for colorectal cancer, including stage II patients","volume":"2016","author":"Shiga","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"issue":"10","key":"10.1016\/j.advnut.2025.100464_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007310","article-title":"Increased interleukin-6\/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer","volume":"11","author":"Naqash","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"51","key":"10.1016\/j.advnut.2025.100464_bib50","doi-asserted-by":"crossref","first-page":"29820","DOI":"10.18632\/oncotarget.25661","article-title":"Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer","volume":"9","author":"Vainer","year":"2018","journal-title":"Oncotarget"},{"issue":"34","key":"10.1016\/j.advnut.2025.100464_bib51","doi-asserted-by":"crossref","first-page":"55765","DOI":"10.18632\/oncotarget.9910","article-title":"Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN J. Parenter. Enteral. Nutr."},{"key":"10.1016\/j.advnut.2025.100464_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737155","article-title":"Prognostic role of the C-reactive protein\/albumin ratio in patients with gynecological cancers: a meta-analysis","volume":"11","author":"Fang","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.advnut.2025.100464_bib54","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1245\/s10434-024-14961-2","article-title":"C-reactive protein\/albumin ratio is an independent risk factor for recurrence and survival following curative resection of stage I-III colorectal cancer in older patients","volume":"31","author":"Bekki","year":"2024","journal-title":"Ann. Surg. Oncol."},{"issue":"16","key":"10.1016\/j.advnut.2025.100464_bib55","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25933","article-title":"Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer","volume":"117","author":"Murphy","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.advnut.2025.100464_bib56","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cncr.25709","article-title":"Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy","volume":"117","author":"Murphy","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clnu.2015.04.013","article-title":"A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer","volume":"35","author":"Mocellin","year":"2016","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.advnut.2025.100464_bib59","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3390\/cancers14082041","article-title":"Multi-omics approach points to the importance of oxylipins metabolism in early-stage breast cancer","volume":"14","author":"Chistyakov","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.advnut.2025.100464_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702785","article-title":"Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities","volume":"12","author":"Lavy","year":"2021","journal-title":"Front. Immunol."},{"issue":"35","key":"10.1016\/j.advnut.2025.100464_bib61","doi-asserted-by":"crossref","first-page":"21576","DOI":"10.1073\/pnas.2007412117","article-title":"Resolution of eicosanoid\/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression","volume":"117","author":"Fishbein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.20170681","article-title":"Resolvins suppress tumor growth and enhance cancer therapy","volume":"215","author":"Sulciner","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib63","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1017\/S0007114508199482","volume":"102","author":"Xue","year":"2009","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1186\/s12885-020-07429-5","article-title":"Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis","volume":"20","author":"Mazaki","year":"2020","journal-title":"BMC Cancer"},{"issue":"45","key":"10.1016\/j.advnut.2025.100464_bib65","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008101","article-title":"Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: a meta-analysis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the tumor microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.advnut.2025.100464_bib67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/2326-6066.CIR-23-0359","article-title":"The omega-3 polyunsaturated fatty acid docosahexaenoic acid enhances NK-cell antitumor effector functions","volume":"12","author":"Wu","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.advnut.2025.100464_bib68","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1194\/jlr.M042457","article-title":"n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity","volume":"54","author":"Teague","year":"2013","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-015-0669-x","article-title":"Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer","volume":"18","author":"Verma","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.advnut.2025.100464_bib70","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clnu.2014.12.002","article-title":"Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: a double-blind randomized clinical trial","volume":"34","author":"Talvas","year":"2015","journal-title":"Clin. Nutr."},{"issue":"10","key":"10.1016\/j.advnut.2025.100464_bib71","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.clnu.2022.07.039","article-title":"Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: a systematic review of randomised controlled trials","volume":"41","author":"Miller","year":"2022","journal-title":"Clin. Nutr."},{"issue":"5","key":"10.1016\/j.advnut.2025.100464_bib72","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.advnut.2025.100464_bib73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clnesp.2023.12.150","article-title":"A dose-response meta-analysis of randomized clinical trials investigating the effects of omega-3 supplementation on body weight in patients with cancer cachexia","volume":"59","author":"Hosseini","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.advnut.2025.100464_bib74","article-title":"Omega-3 fatty acid supplementation and its impact on systemic inflammation and body weight in patients with cancer cachexia-a systematic review and meta-analysis","volume":"8","author":"de Castro","year":"2021","journal-title":"Front. Nutr."},{"issue":"7","key":"10.1016\/j.advnut.2025.100464_bib75","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11745-000-0583-1","article-title":"Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function","volume":"35","author":"Healy","year":"2000","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.advnut.2025.100464_bib76","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/sj.bjc.6600659","article-title":"Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation","volume":"87","author":"Pratt","year":"2002","journal-title":"Br. J. Cancer."},{"issue":"3","key":"10.1016\/j.advnut.2025.100464_bib77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.clnu.2014.11.005","article-title":"Omega-3 supplements for patients in chemotherapy and\/or radiotherapy: a systematic review","volume":"34","author":"de Aguiar Pastore Silva","year":"2015","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.advnut.2025.100464_bib78","first-page":"82","article-title":"N - 3 fatty acids during chemotherapy: toward a higher level of evidence for clinical application","volume":"23","author":"Klassen","year":"2020","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.advnut.2025.100464_bib79","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clnesp.2024.11.014","article-title":"The effects of Omega-3 fatty acids and vitamin D supplementation on the quality of life and blood inflammation markers in newly diagnosed breast cancer women: An open-labelled randomised controlled trial","volume":"65","author":"Almassri","year":"2025","journal-title":"Clin. Nutr. ESPEN."},{"issue":"12","key":"10.1016\/j.advnut.2025.100464_bib80","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/ijms18122607","article-title":"Determination of the relative efficacy of eicosapentaenoic acid and docosahexaenoic acid for anti-cancer effects in human breast cancer models","volume":"18","author":"VanderSluis","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.advnut.2025.100464_bib81","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2009.01.004","article-title":"Comparative effects of DHA and EPA on cell function","volume":"122","author":"Gorjao","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.advnut.2025.100464_bib82","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/md10112535","article-title":"Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids","volume":"10","author":"Russell","year":"2012","journal-title":"Mar. Drugs."}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831325001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831325001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:19:12Z","timestamp":1762600752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831325001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2161831325001000"],"URL":"https:\/\/doi.org\/10.1016\/j.advnut.2025.100464","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspective: Implications of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on the Immune System during Cancer Chemotherapy: Perspectives from Current Clinical Evidence","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advnut.2025.100464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"100464"}}